Ginkgo Bioworks Holdings, Inc.
DNA- Exchange
- NYSE
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001830214
In the last 90 days, Ginkgo Bioworks Holdings, Inc. insiders filed 0 open-market purchases and 3 sales; 183 institutions reported holding it in 13F filings for Q2 2026, worth $359.2M in total; Viking Global Investors is the only superinvestor holding it.
Q3 2021 vs. Q2 2021
How the institutions holding Ginkgo Bioworks Holdings, Inc. changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Q3 2021 | Change |
|---|---|---|---|
| Holders | 0 | 125 | +125 |
| Shares | 0 | 792.1M | +792.1M |
| Value | $0 | $9.18B | +$9.18B |
New holders (125)
Institutions that held Ginkgo Bioworks Holdings, Inc. at the end of Q3 2021 but not at the end of Q2 2021.
Showing the largest 100 of 125 by value.
Sold out (0)
Institutions that held Ginkgo Bioworks Holdings, Inc. at the end of Q2 2021 and filed for Q3 2021 without it.
None.